摘要
目的研究苇茎汤在慢性支气管炎合并肺气肿患者中的应用效果。方法将2018年1月至2020年1月收治的200例慢性支气管炎合并肺气肿患者作为本次研究对象,按照入院顺序将其分为对照组和观察组,每组100例。对照组采用常规西医治疗,观察组在此基础上采用苇茎汤治疗。比较两组的症状缓解时间、肺功能指标、不良反应发生情况以及治疗效果。结果观察组患者咳嗽、咳痰、喘息、哮鸣音缓解时间均短于对照组(P<0.05)。治疗后,两组的FEV1、FEV1/FVC均提高,且观察组高于对照组(P<0.05)。观察组的不良反应总发生率低于对照组(P<0.05)。观察组的治疗总有效率高于对照组(P<0.05)。结论苇茎汤治疗慢性支气管炎合并肺气肿患者效果显著,且安全性极高,值得研究和推广。
Objective To study the application effect of Weijing decoction in patients with chronic bronchitis and pulmonary emphysema.Methods From January 2018 to January 2020,200 patients with chronic bronchitis and pulmonary emphysema were selected as the research objects and divided into control group and observation group according to the order of admission,with 100 cases in each group.The control group was treated with conventional western medicine,and the observation group was treated with Weijing decoction on this basis.The symptom relief time,pulmonary function indexes,adverse reactions and treatment effects were compared between the two groups.Results The remission time of cough,expectoration,pant and wheezing rale in the observation group were shorter than those in the control group(P<0.05).After treatment,FEV1 and FEV1/FVC of the two groups increased,and those in the observation group were higher than the control group(P<0.05).The total incidence of adverse reactions in the observation group was lower than that in the control group(P<0.05).The total effective rate of treatment in the observation group was higher than that of the control group(P<0.05).Conclusion Weijing decoction in the treatment of chronic bronchitis and pulmonary emphysema has significant effect and high safety,which is worthy of research and promotion.
作者
强卫平
怡文辉
万虹
时芸芸
QIANG Weiping;YI Wenhui;WAN Hong;SHI Yunyun(Xi'an Traditional Chinese Medicine Hospital of Encephalopathy,Xi'an 710038,China)
出处
《临床医学研究与实践》
2020年第23期147-148,160,共3页
Clinical Research and Practice
关键词
苇茎汤
慢性支气管炎
肺气肿
Weijing decoction
chronic bronchitis
pulmonary emphysema
